(Reuters Health)—Adults 50 years and older who take tumor necrosis factor inhibitors (TNFi’s) for a range of inflammatory disorders can receive effective protection from shingles… [Read More]
Latest News
Severe COVID-19 May Trigger Autoimmunity
Practical Ways to Manage Cardiovascular Risk in Patients with Psoriatic Arthritis
The Role of ANA Positivity in Patients with RA
Nonserious Infection Rates with Biologics Used to Treat RA
Bechman et al. set out to describe the frequency and predictors of nonserious infections and compare incidence rates across biologic DMARDs. They found all bDMARDs are associated with a greater risk of nonserious infection, with differences observed between agents. Although unmeasured confounding must be considered, the magnitude of effect is large. [Read More]
Experts Share Insights & Advice on Reproductive Health for Patients with Rheumatic Disease
Sponsored Content
Sponsored by Our Lab is Everywhere
Clinical evidence may help patients' changing needs.
See the story behind the moderate to severe RA study that reveals outcomes of one biologic monotherapy.USA-916-82440
LEARN MORE